Skip to content

Treatment breaks set for a come-back?

Modern HIV treatment can work well with adherence below 95%

Kivexa downgraded to alternative status in revised US HIV treatment guidelines

Starting HIV treatment soon after a patient is diagnosed with cryptococcal meningitis decreases risk of death

Can we create ‘elite controllers’?

Migrants with MDR-TB in southern Africa being dumped off at borders without referrals to care

Plasma concentrations of rifampicin may be too low in children using currently recommended doses

Enhanced Trofile assay better at identifying HIV tropisms, only slight impact on virologic outcomes

Once-daily darunavir/ritonavir may be an option for some treatment-experienced patients